Candel Therapeutics, Inc. (CADL) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$9.15
+5.03%
Mkt Cap $615.21M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.24 | -$0.54 | -125.00% |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.17 | -$0.21 | -23.53% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.17 | -$0.09 | +47.06% |
| Q2 2025 May 13, 2025 | — | — | — | -$0.24 | $0.13 | +154.17% |
| Q1 2025 Mar 13, 2025 | — | — | — | -$0.23 | -$0.40 | -73.91% |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$0.33 | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$0.74 | — |
| Q2 2024 May 14, 2024 | — | — | — | — | -$0.28 | — |
| Q1 2024 Mar 28, 2024 | — | $1.78M | — | -$0.16 | -$0.38 | -137.50% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.19 | -$0.29 | -52.63% |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.23 | -$0.33 | -43.48% |
| Q2 2023 May 11, 2023 | — | — | — | -$0.35 | -$0.30 | +14.29% |
| Q1 2023 Mar 30, 2023 | $13.00K | $31.00K | +138.46% | -$0.16 | -$0.18 | -12.50% |
| Q4 2022 Nov 10, 2022 | $15.50K | $31.00K | +100.00% | -$0.53 | -$0.30 | +43.40% |
| Q3 2022 Aug 5, 2022 | — | $31.00K | — | -$0.54 | -$0.14 | +74.07% |
| Q2 2022 May 12, 2022 | $20.67K | $31.00K | +50.00% | -$0.49 | -$0.03 | +93.88% |
| Q1 2022 Mar 29, 2022 | $15.00K | $31.00K | +106.67% | -$0.32 | $0.05 | +115.63% |
| Q4 2021 Nov 12, 2021 | $22.96K | $31.00K | +35.01% | -$0.27 | -$0.34 | -25.93% |
| Q3 2021 Sep 8, 2021 | — | $31.00K | — | -$0.12 | -$0.31 | -158.33% |
| Q3 2021 Jul 28, 2021 | — | $31.00K | — | — | -$0.24 | — |
| Q4 2020 Dec 31, 2020 | — | $31.00K | — | — | -$0.56 | — |
| Q3 2020 Sep 30, 2020 | — | $31.00K | — | — | -$0.14 | — |
| Q2 2020 Jun 30, 2020 | — | $31.00K | — | — | -$0.15 | — |
| Q1 2020 Mar 31, 2020 | — | $31.00K | — | — | -$0.09 | — |